100% Quality Guarantee
PhD-Level Technical Support
Key Features

PE Anti-Human CD28 Antibody [CD28.2] (AGEL2021)

SKU AGEL2021
Product Type Antibody
Antibody Type Monoclonal Antibody
Reactivity Human
Applications FC
€68 - €285

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

PE Anti-Human CD28 Antibody [CD28.2]

The Human CD28 Monoclonal Antibody PE Conjugated (CD28-2) is a specialized tool designed for researchers studying CD28, a crucial co-stimulatory molecule essential for T cell activation and immune response regulation. This antibody, conjugated with PE for fluorescence detection, offers high specificity and sensitivity towards human CD28 samples.With its ability to bind specifically to CD28 protein, this monoclonal antibody enables precise detection and quantification of CD28 expression in various cell types. The PE conjugation enhances visibility and allows for flow cytometry analysis, making it ideal for investigating immune responses, T cell activation, and immunotherapy research.

CD28 is a key receptor involved in T cell activation and immune signaling pathways, playing a pivotal role in modulating adaptive immune responses. Research focused on CD28 is critical for understanding immune system function, autoimmunity, transplant rejection, and immunotherapy development.By utilizing the Human CD28 Monoclonal Antibody PE Conjugated (CD28-2), researchers can delve deeper into the intricate mechanisms of immune regulation and T cell activation, paving the way for advancements in immunology, cancer immunotherapy, and autoimmune disease research.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose